About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Epilepsy Clinical Trials in New York | 30 Studies

Clinical Trials EpilepsyNew York

Epilepsy Clinical Trials in New York

Find 30 clinical trials for epilepsy near New York, New York. Connect with research centers in your area.

All Epilepsy trials nationwide All trials in New York

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 21-30 of 30 trials

CompletedRegistry of Subjects With Drug Resistant Epilepsy and Treated With the VNS Therapy System.Multicenter global post-market registry of subjects diagnosed with drug resistant epilepsy and treated with the VNS Therapy System.NCT03529045·Grand Junction, Colorado and 61 others

Epilepsy Trials in Other Cities

Los Angeles Chicago Houston Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

CompletedA Trial of the Efficacy and Safety of CVL-865 as Adjunctive Therapy in the Treatment of Focal Onset SeizuresThe goal of this clinical trial is to learn if CVL-865, when taken regularly with other anti-seizure medicines, works to prevent seizures in adults with drug-resistant focal onset…NCT04244175·Little Rock, Arkansas and 75 others

Enrolling by invitationAn Open-label Study of XEN1101 in EpilepsyThis study will evaluate the long term safety, tolerability, pharmacokinetics (PK), and efficacy of XEN1101 in subjects with Focal Onset Seizures (FOS) or Primary Generalized…NCT05718817·Phoenix, Arizona and 151 others

CompletedRepeat Dose Safety Study of NRL-1 in Epilepsy SubjectsThis is a 12 month safety study to evaluate the safety of repeated doses of NRL-1NCT02721069·Little Rock, Arkansas and 4 others

Not yet recruitingCOMparison Between Anakinra and Tocilizumab in NORSE - "COMBAT-NORSE"The goal of this clinical trial is to find out whether two existing medications-anakinra and tocilizumab-can effectively treat a rare and life-threatening brain condition called…NCT07281027·Phoenix, Arizona and 32 others

TerminatedStudy to Evaluate the Safety and Efficacy of USL261 (Intranasal Midazolam) in Patients With Seizure ClustersThe purpose of this study is to examine the safety and effectiveness of USL261 for the outpatient treatment of seizure clusters.NCT01390220·Phoenix, Arizona and 89 others

TerminatedIntrinsic Optical Imaging Study to Map Neocortical Seizure in Human Epilepsy PatientsThe purpose of this study is to develop a technique for the intraoperative identification of human functional and epileptiform cortex using intrinsic signal imaging.NCT00195052·New York, New York

CompletedRufinamide Given as Adjunctive Therapy in Participants With Refractory Partial SeizuresTo evaluate the effect of rufinamide on total partial seizure frequency in adolescent and adult participants (12 to 80 years, inclusive) with refractory partial onset seizures…NCT00334958·Mobile, Alabama and 76 others

CompletedHormone Replacement in Menopausal Women With EpilepsyThe goal of this study is to evaluate the effect of synthetic hormone replacement therapy on anti-seizure medication levels, menopausal symptom relief, and seizure frequency and…NCT00027209·New York, New York

CompletedA Randomized Study of XEN1101 Versus Placebo in Focal-Onset SeizuresThe X-TOLE2 Phase 3 clinical trial is a randomized, double-blind, placebo-controlled study that will evaluate the clinical efficacy, safety and tolerability of XEN1101…NCT05614063·Mobile, Alabama and 124 others

PreviousPage 2 of 2

Other Conditions in New York

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia